Thyroid collision tumour with pulmonary metastases treated effectively with nedaplatin and paclitaxel chemotherapy: A case report

Overview of the 2022 WHO Classification of Thyroid Neoplasms

(2022) Zubair W. Baloch et al.   ENDOCRINE PATHOLOGY

Synchronous Hürthle cell and medullary thyroid carcinomas

(2022) Zhu Hui Yeap et al.   BMJ Case Reports

Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid

(2022) Xiaofei Wang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

(2022) Peng Fan et al.   Frontiers in Immunology

Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1)

(2022) Dongcheng Luo et al.   Frontiers in Oncology

Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease

(2021) Eman A. Toraih et al.   Cancers

Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis

(2021) Andrés Coca-Pelaz et al.   ADVANCES IN THERAPY

Collision tumors: A review of their types, pathogenesis, and diagnostic challenges

(2020) Camille A. Bulte et al.   Dermatologic Therapy

Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

(2020) Naoya Kitamura et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ovarian collision tumors: imaging findings, pathological characteristics, diagnosis, and differential diagnosis

(2017) Yang Peng et al.   Abdominal Radiology

Hürthle cell carcinoma: current perspectives

(2016) Sara Ahmadi et al.   OncoTargets and Therapy

Collision tumors of the thyroid: A case report and review of the literature

(2015) Neil Ryan et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

(2014) Marcia S Brose et al.   LANCET

Successful Treatment of Hurthle Cell Thyroid Carcinoma with Lung and Liver Metastasis Using Docetaxel and Cisplatin

(2012) H. Zhang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY